FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 08:00:06 24/05/2024 BST | ||
| 18.13 EUR | +0.83% |
|
| Current month | -30.95% | ||
| 1 month | -31.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 18.13 | +0.83% |
| 23/05/24 | 17.98 | +2.74% |
| 22/05/24 | 17.5 | +0.86% |
| 21/05/24 | 17.35 | +0.41% |
| 20/05/24 | 17.28 | -1.03% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 08:00 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GG2BL0 |
| ISIN | DE000GG2BL01 |
| Date issued | 09/01/2024 |
| Strike | 459.8 $ |
| Maturity | Unlimited |
| Parity | 8.04 : 1 |
| Emission price | 20.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 28.77 € |
|---|---|
| Lowest since issue | 16.74 € |
| Spread | 0.1 € |
| Spread % | 0.55% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306.5
USD
Average target price
316.1
USD
Spread / Average Target
+3.12%
- Stock Market
- Certificates
- Certificat
